Case Type: Mergers & Acquisitions

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), relating to the proposed merger with Decoy Therapeutics, Inc. Under the terms of the agreement, Salarius stockholders would own approximately 14% of the outstanding shares of the combined company.

H&E Equipment Services, Inc. (Nasdaq: HEES), relating to the proposed merger with United Rentals, Inc. Under the terms of the agreement, United Rentals will acquire H&E for $92 per share in cash.

Enfusion, Inc. (NYSE: ENFN), relating to the proposed merger with Clearwater Analytics. Under the terms of the agreement, Enfusion shareholders will receive $5.85 per share in cash and $5.40 per share in Clearwater Class A Common Stock.

Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), relating to the proposed merger with Johnson & Johnson. Under the terms of the agreement, Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies for a payment of $132.00 per share in cash.

CNB Financial Corporation (Nasdaq: CCNE), relating to the proposed merger with ESSA Bancorp, Inc. Under the terms of the agreement, ESSA shareholders will receive 0.8547 shares of CNB common stock for each outstanding share of ESSA common stock.

ESSA Bancorp, Inc. (Nasdaq: ESSA), relating to the proposed merger with CNB Financial Corporation. Under the terms of the agreement, ESSA shareholders will receive 0.8547 shares of CNB common stock for each outstanding share of ESSA common stock.

Akoya Biosciences, Inc. (Nasdaq: AKYA), relating to the proposed merger with Quanterix. Under the terms of the agreement, Akoya shareholders will receive 0.318 shares of Quanterix common stock for each share of Akoya common stock owned. Akoya shareholders will own approximately 30% of the combined company.

Quanterix Corporation (Nasdaq: QTRX), relating to the proposed merger with Akoya Biosciences. Under the terms of the agreement, Akoya shareholders will receive 0.318 shares of Quanterix common stock for each share of Akoya common stock owned. Quanterix shareholders will own approximately 70% of the combined company.

Yerbaé Brands Corp. (OTC: YERBF), relating to the proposed merger with Safety Shot, Inc. Under the terms of the agreement, each holder of Yerbaé Shares is expected to receive 0.2918 of a Safety Shot Share for each Yerbaé Share held. Former holders of Yerbaé Shares are expected to own approximately 24.2% of the combined company.

Safety Shot, Inc. (Nasdaq: SHOT), relating to the proposed merger with Yerbaé Brands Corp. Under the terms of the agreement, each holder of Yerbaé Shares is expected to receive 0.2918 of a Safety Shot Share for each Yerbaé Share held. Safety Shot shareholders are expected to own approximately 75.8% of the combined company.